Evidence map›Paper›PMID 28584144›Full record

ArticleAntimicrobial agents and chemotherapy2017

Peptide Inhibitors Targeting the Neisseria gonorrhoeae Pivotal Anaerobic Respiration Factor AniA.

Aleksandra E Sikora, Robert H Mills, Jacob V Weber, Adel Hamza, Bryan W Passow, Andrew Romaine, Zachary A Williamson, Robert W Reed, Ryszard A Zielke, Konstantin V Korotkov

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 43 citations in OpenAlex.

  1. AccA fromChemical science · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Biomolecules · 2021
    Article
  9. Article
  10. Anti-Virulence Therapeutic Approaches forAntibiotics (Basel, Switzerland) · 2021
    Review
  11. Article
  12. Quantitative Proteomics of the 2016 WHOMolecular & cellular proteomics : MCP · 2019
    Article
  13. Future Prospects forAntibiotics (Basel, Switzerland) · 2018
    Review
  14. Review
  15. Lipid-Modified Azurin ofFrontiers in microbiology · 2018
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Aleksandra E SikoraDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA Aleksandra.Sikora@oregonstate.edu.ORCID 0000-0001-7977-2596
Robert H MillsDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA.
Jacob V WeberDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA.
Adel HamzaDepartment of Molecular & Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Bryan W PassowDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA.
Andrew RomaineDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA.
Zachary A WilliamsonDepartment of Molecular & Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Robert W ReedDepartment of Molecular & Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Ryszard A ZielkeDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA.
Konstantin V KorotkovDepartment of Molecular & Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Oregon State University · USUniversity of Kentucky · US

Funding

Proteomics-Driven Reverse Vaccinology for GonorrheaR01AI117235 · NIAID · OREGON STATE UNIVERSITY · PI Aleksandra Elzbieta Sikora · 2015 to 2026
$6.7M
Protein CoreP30GM110787 · NIGMS · UNIVERSITY OF KENTUCKY · PI WHITEHEART, SIDNEY WALDO · 2014 to 2018
$5.7M
Center for Biomedical Research Excellence in the Molecular Basis of Human DiseaseP20GM103486 · NIGMS · UNIVERSITY OF KENTUCKY · PI LOUIS HERSH, LOUIS HERSH LOUIS HERSH · 2012 to 2013
$4.2M
NIAID NIH HHS R01 AI117235NIGMS NIH HHS P20 GM103486NIGMS NIH HHS P30 GM110787
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnaerobiosisAntigens, BacterialBacterial Outer Membrane ProteinsCell Surface Display TechniquesCrystallizationEnzyme-Linked Immunosorbent AssayGonorrheaHumansMicrobial Sensitivity TestsModels, MolecularModels, StructuralMutagenesis, Site-DirectedNeisseria gonorrhoeaeNitrite ReductasesNitritesOxygenaniA protein, Neisseria gonorrhoeaeAntigens, BacterialBacterial Outer Membrane ProteinsNitrite ReductasesNitritesOxygenPeptidesanaerobic respirationAniAbiolayer interferometrycrystal structuredocking studiesNeisseria gonorrhoeaenitrite reductasepeptide inhibitorsphage display

Identifiers

PMID28584144
PMCPMC5527597
OpenAlexW2622520493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.